Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aviron -- Ignore unavailable to you. Want to Upgrade?

To: Dennis who wrote (468)	5/4/1999 10:02:00 PM
From: John Finley	Read Replies (1) \| Respond to of 645

Dennis, I think you'll probably have time to contemplate buying AVIR at these levels or better for a while. The only thing I can see that is going to give us a little pop may be when a bridging study is completed to determine if the production manufacturing technique yields Flumist as effective as that used in the previous studies. Also might see a little action when they submit their application to the FDA again. All in all I should have sold at 25 also <g>. In the long run, however, the potential is great. Unfortunately the risk is high too. JF